Biogen (NASDAQ:BIIB) Set to announce 4Q16 Earnings On 26th January 2017


Biogen (NASDAQ:BIIB) biotech drug manufacturer, is reporting fourth quarter earnings results on Thursday 26th January 2017, before the bell.
The consensus estimates from Thomson Reuters are income of $ 4.97 per share from $ 2.94 billion in revenue.

The same period from last year, BIIB reportedly had income of $ 4.50 per share on $ 2.84 billion in revenue.

For the full year, analysts predict revenues of $ 11.52 billion, while looking forward to income of $ 20.17 per share.